Skip to content

Form 4 filed by van Houte Hans

van Houte Hans filed this Form 4 on NRIX (Nurix Therapeutics, Inc.) with 7 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-03 00:47:02 UTC.

Accession
0001817217-26-000014
Filed
2026-11-02
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: NRIX · Nurix Therapeutics, Inc. (CIK 1549595)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-10-30M exercised+3,750$043,916D
Common Stock 2026-10-30M exercised+2,859$046,775D
Common Stock 2026-10-30M exercised+3,573$050,348D
Common Stock 2026-10-30S sold-2,834$26.279147,514D
Restricted Stock Units derivative2026-10-30M exercised-3,750$07,500D
Restricted Stock Units derivative2026-10-30M exercised-2,859$017,150D
Restricted Stock Units derivative2026-10-30M exercised-3,573$035,730D